返回
AIM Vaccine Co., Ltd.（06660.HK）價格
06660.HK 股價走勢圖
AIM VACCINE (06660.HK)
AIM Vaccine Co., Ltd.
HK$3.39
-5.83%
$-0.2
休市： Jan 19, 16:00:00 HKT
暫無資料Follow-Up Questions
AIM Vaccine Co., Ltd. 的關鍵財務報表是什麼？
06660.HK 的關鍵財務比率是什麼？
AIM Vaccine Co., Ltd. 的收入按細分市場或地理位置如何劃分？
AIM Vaccine Co., Ltd. 是否盈利？
AIM Vaccine Co., Ltd. 有負債嗎？
AIM Vaccine Co., Ltd. 的流通股有多少？
關鍵數據
前收市價
$3.69
開盤價
$3.6
當日範圍
$3.38 - $3.6
52週區間
$3.03 - $6.55
交易量
1.7M
平均成交量
599.5K
每股盈餘 (TTM)
-0.26
股息收益率
--
市值
$1.7B
什麼是 AIM VACCINE？
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. The company is headquartered in Beijing, Beijing and currently employs 1,493 full-time employees. The company went IPO on 2022-10-06. The firm's commercialized products mainly include recombinant HBV vaccine, freeze dried human rabies vaccine, inactivated HAV vaccine, mumps vaccine, bivalent inactivated HFRS vaccine and Group A, C, Y and W135 MPSV. The firm's vaccine products under development include 13-Valent Pneumonia Conjugate Vaccine, 24-Valent Pneumonia Conjugate Vaccine, quadrivalent influenza virus vaccine, iterative serum-free rabies vaccine, mRNA shingles/herpes zoster vaccine, Iterative mRNA rabies vaccine, mRNA respiratory syncytial virus vaccine, novel-process highly-effective human diploid rabies vaccine, and others.